News & Updates
Filter by Specialty:
Emphysema increases susceptibility to chronic pulmonary aspergillosis
Among patients with Mycobacterium avium complex pulmonary disease, the risk of chronic pulmonary aspergillosis development and mortality is high in the presence of emphysema, according to a study.
Emphysema increases susceptibility to chronic pulmonary aspergillosis
14 Jan 2022
GI symptoms in COVID-19 more prevalent than previously reported
There appears to be a higher prevalence of gastrointestinal (GI) symptoms in hospitalized patients with COVID-19 than previously reported, reveals a recent study.
GI symptoms in COVID-19 more prevalent than previously reported
13 Jan 2022
Breakthrough infections with COVID-19 Delta variant linked to lower memory B cell response
The memory B cell response appears to be weaker in vaccinated individuals who develop breakthrough infections with the Delta variant of the coronavirus disease 2019 (COVID-19), according to a new Singapore study.
Breakthrough infections with COVID-19 Delta variant linked to lower memory B cell response
13 Jan 2022
Smokers more likely to develop COVID-19 complications
Among patients with COVID-19 infection, those who smoke are at higher risk of developing complications compared with those who do not smoke, according to a study from Malaysia.
Smokers more likely to develop COVID-19 complications
13 Jan 2022
More than 1 in 4 young adults test seropositive for COVID-19
A recent study has shown that more than a quarter of young adults are seropositive for SARS-CoV-2, many of whom show single positivity with IgM. Such seropositivity was higher among those who had cases of the coronavirus disease 2019 (COVID-19) in the household and those who used public transport.
More than 1 in 4 young adults test seropositive for COVID-19
12 Jan 2022
Do antihypertensive drugs raise odds of COVID-19 diagnosis, death?
Antihypertensive therapy (AHT) may be used safely during the COVID-19 pandemic, as no evidence suggest that it can increase the risk of SARS-CoV-2 infection or death, according to a UK study. In addition, most classes of antihypertensives are negatively associated with COVID-19 diagnosis.
Do antihypertensive drugs raise odds of COVID-19 diagnosis, death?
12 Jan 2022
Cardiovascular drugs do not worsen COVID-19 outcomes
Use of cardiovascular medications does not lead to poor COVID-19 clinical outcomes among high-risk patients, such as those with hypertension, according to a study.
Cardiovascular drugs do not worsen COVID-19 outcomes
11 Jan 2022
COVID-19 vaccines safe for patients with rheumatic, musculoskeletal disease
Vaccines against SARS-CoV-2 has a safety profile that is similar in patients with inflammatory/autoimmune rheumatic and musculoskeletal disease (I-RMD) and those with noninflammatory RMD (NI-RMD), according to a study. The vaccines are well tolerated with rare reports of I-RMD flare and serious adverse events.
COVID-19 vaccines safe for patients with rheumatic, musculoskeletal disease
11 Jan 2022
5α-reductase inhibitors help reduce SARS-CoV-2 infection risk in men
Use of 5α-reductase inhibitors (5ARIs) appears to lower the risk of community-acquired infection with SARS-CoV-2 in men without prostate cancer, according to a study, noting that treatment with this drug class can help ease the burden of COVID-19.